This strategic acquisition combines
BioCentric's medical affairs and commercial expertise with JPA
Health's integrated services, predictive analytics and AI-driven
solutions
WASHINGTON, May 24, 2024 /PRNewswire/ -- JPA Health, a
global full-service, integrated health agency, announced the
acquisition of BioCentric, Inc., an award-winning medical
communications agency. BioCentric is recognized for its work with
leading pharmaceutical companies, supporting them with scientific
platforms for pipeline product candidates, clinical trial
acceleration, and HCP engagement.
BioCentric will serve as JPA Health's medical communications and
learning experiences arm, leveraging its innovative serious games
and gamification approach to enhance engagements, capture
meaningful insights, and drive positive behavior
change. Sherine Aly, who founded BioCentric in 2001, will
continue to lead the division, ensuring clients receive exceptional
scientific communications solutions. BioCentric has offices in
Collingswood, N.J., and Lausanne,
Switzerland.
"We are thrilled to welcome BioCentric into the growing JPA
Health family," said Carrie Jones,
CEO of JPA Health. "This acquisition is a great union, bringing
together BioCentric's medical prowess with JPA's deeply rooted
expertise across marketing, patient advocacy, and corporate
communications. Our clients will benefit from a fully integrated
agency that can deliver unparalleled solutions to help them achieve
their goals efficiently and effectively."
"Joining JPA Health allows us to elevate our work to new
heights. Our shared commitment to improving lives by connecting
healthcare stakeholders and leveraging the latest technological
innovations will unlock powerful and creative
synergies," said Sherine Aly,
Executive Vice President, Medical Communications. "Together, we can
now offer our clients end-to-end solutions that make a real
difference in patients' lives."
This acquisition follows JPA Health's purchase of True North
Solutions in September 2023, further
expanding the agency's capabilities in predictive analytics, AI,
and natural language processing. With the integration of True North
Solutions and BioCentric, JPA Health continues to build on its
mission to provide comprehensive, data-driven, and high-impact
services to clients across the life sciences, public health, one
health, and federal government sectors.
The combined agency has more than 120 employees across offices
in the U.S. and Europe, offering a
synergistic suite of services that includes corporate
communications, brand marketing, patient engagement, and scientific
storytelling. This integration is rooted in the shared values and
vision of both organizations, deeply committed to advancing
medicine and improving health outcomes.
For more information about JPA Health and its comprehensive
suite of services, please visit www.jpa.com.
JPA Health
JPA Health is an award-winning independent,
full-service agency established in 2007. With offices across the
U.S. and Europe, the agency
seamlessly brings together flexible solutions in public relations,
commercial marketing, patient advocacy, and medical communications
across the health sector. Leveraging tailored AI solutions, JPA
Health crafts seamless, 360-degree omnichannel strategies to engage
healthcare stakeholders effectively. As a women-owned and
independent agency, we are passionate about helping people live
healthier lives and dedicated to pushing the boundaries of
healthcare communications. Discover more at www.jpa.com.
BioCentric – A JPA Health Company
BioCentric is an
award-winning medical communications and learning experiences
agency that supports a broad range of drug development and
commercialization activities. With expertise in behavioral science,
modern learning principles, and game mechanics, BioCentric creates
value-based, customer-centric experiences to improve patient
care.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/jpa-health-expands-capabilities-with-the-acquisition-of-biocentric-inc-302154723.html
SOURCE JPA Health